Happiness Development Group (NASDAQ:HAPP – Get Rating) and MariMed (OTCMKTS:MRMD – Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, risk, profitability and valuation.
Insider & Institutional Ownership
1.4% of Happiness Development Group shares are owned by institutional investors. Comparatively, 0.3% of MariMed shares are owned by institutional investors. 20.0% of MariMed shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
This table compares Happiness Development Group and MariMed’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Happiness Development Group||N/A||N/A||N/A|
Valuation & Earnings
This table compares Happiness Development Group and MariMed’s revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Happiness Development Group||$71.49 million||0.09||$790,000.00||N/A||N/A|
|MariMed||$121.46 million||1.27||$7.22 million||$0.02||22.77|
MariMed has higher revenue and earnings than Happiness Development Group.
This is a breakdown of recent ratings and price targets for Happiness Development Group and MariMed, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Happiness Development Group||0||0||0||0||N/A|
MariMed has a consensus target price of $2.25, indicating a potential upside of 394.40%. Given MariMed’s higher probable upside, analysts plainly believe MariMed is more favorable than Happiness Development Group.
Risk & Volatility
Happiness Development Group has a beta of 0.67, indicating that its stock price is 33% less volatile than the S&P 500. Comparatively, MariMed has a beta of 3.24, indicating that its stock price is 224% more volatile than the S&P 500.
MariMed beats Happiness Development Group on 10 of the 11 factors compared between the two stocks.
Happiness Development Group Company Profile (Get Rating)
Happiness Development Group Limited engages in the research, development, manufacture, and sale of nutraceutical and dietary supplement products in the People's Republic of China and internationally. The company's product category includes lucidum spore powders, cordyceps mycelia, Ejiao products, American ginseng products, other traditional Chinese herbal and animal extracts, vitamins, minerals, and amino acids. It sells its products through distributors, large-scale chain drugstores, malls, and supermarkets under the Happiness brand. The company was formerly known as Happiness Biotech Group Limited and changed its name to Happiness Development Group Limited in November 2021. Happiness Development Group Limited was founded in 2004 and is headquartered in Nanping, the People's Republic of China.
MariMed Company Profile (Get Rating)
MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company offers cannabis genetics produce flowers and concentrates under the Nature's Heritage brand; cannabis-infused products in the form of chewable tablets and powder drink mixes under the brand Kalm Fusion; natural fruit chews under the Betty's Eddies brand; brownies, cookies, and other social sweets under the Bubby's Baked brand; and cannabidiol formulations under the Florance brand. It also licenses its brands and product formulations, as well as leases cannabis facilities. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.
Receive News & Ratings for Happiness Development Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Happiness Development Group and related companies with MarketBeat.com's FREE daily email newsletter.